Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cholecalciferol × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 13 Magnetic Resonance Spectroscopy 7 lutetium Lu 177 dotatate 6 Cisplatin 5 gallium Ga 68 dotatate 4 Specimen Handling 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Positron Emission Tomography Computed Tomography 3 Etoposide 3 Carboplatin 3 pembrolizumab 2 pasireotide 2 olaparib 2 dabrafenib 2 Trastuzumab 2 Photochemotherapy 2 Paclitaxel 2 Octreotide 2 Lutetium-177 2 Ipilimumab 2 Iodine-131 2 Ga(III)-DOTATOC 2 FAPI-46 2 Doxorubicin 2 Cyclophosphamide 2 Bortezomib 2 Biopsy 2 (177)Lu-DOTA-EB-TATE 2 zopiclone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02063334 2016-07-29

VitDbol

University of Eastern Finland

Phase 1 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡